Connect with us

Share Market

Coronavirus Stocks To Buy When An Outbreak Occurs

Published

on


This post is more for me than it is for you, and in no way a recommendation to buy these stocks. It is my journal listing of stocks that are moving on volume on the latest Wuhan Coronavirus scare. What do we know so far? Very little as it seems many are keeping this thing under wraps. However, more details are pointing to a more significant threat.

It’s hard to determine what is fact and fiction in this new age of “Fake News” , but here is the current Outbreak map and the RO number:

__

Stocks seeing activity due to the outbreak are as follows (Highest price to lowest price): AZN, MRNA, VIR, LAKE, NNVC, NVAX, APT, ICCC, CERS, INO, AHPI, BCRX, AEMD, CODX, CBLI, LLIT

AZN – engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide

AstraZeneca CEO Pascal Soriot told CNBC. “We have a very large presence in China, and are the number one pharmaceutical company there, we employ 16,000 people — so as you would imagine it matters to us, we really care a lot and we’ll monitor this, but it really looks like it’s contained for the time being.”

___

MRNA – Creating a new category of transformative medicines based on mRNA to improve the lives of patients. From the beginning, we designed our strategy and operations to realize the full potential value and impact of mRNA over a long time horizon across a broad array of human diseases

Note: “MRNA has received new funding from vaccine alliance CEPI to accelerate its work on a coronavirus vaccine, and it has joined forces with the Coalition for Epidemic Preparedness Innovations on a vaccine approach.”

___

VIR – a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Note: “$VIR holds a portfolio that includes an antibody for another coronavirus strain, but management is testing to determine efficacy on the Wuhan strain.”

___

LAKE – The company offers limited use/disposable protective clothing, such as coveralls, lab coats, shirts, pants, hoods, aprons, sleeves, smocks, and shoe covers; high-end chemical protective suits to provide protection from highly concentrated and hazardous chemical and biological toxins; and fire fighting and heat protective apparel, which is used for the maintenance of high temperature equipment, and for military and airport crash and rescue teams.

___

NNVC – NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas

Note: The company announced a secondary offering after the first day spike. Investors gobbled it up, buying the dip like madmen.

___

NVAX – Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants.

Note: Like NNVC, the company has already announced a secondary offering and the stock is recovering from the news.

___

APT – engages in developing, manufacturing, and marketing a line of disposable protective apparel, building supply products, and infection control products in the United States and internationally.

Note: APT is LAKE’s little cousin. They almost always move in tandem with each other.

___

ICCC –  is involved in the development of Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows; and treatments that prevent E. coli K99 and bovine coronavirus, as well as calf scours caused by enteric pathogens.

___

CERS – Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, including viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.

NOTE: Cowen notes that it is encouraged by prior data suggesting that Cerus’s Intercept could be an effective tool against the Coronavirus family.

___

INO – a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

NOTE: “INO is developing a vaccine to treat the MERS strain of coronavirus, management may be able to contribute its research toward the Wuhan coronavirus effort.”

___

AHPI – Allied Healthcare Products, Inc. engages in the manufacture, marketing, and distribution of various respiratory products for a range of hospital and alternate site settings to the health care industry in the United States, Europe, Canada, Latin America, the Middle East, the Far East, and internationally.

Note: A sleeper Coronavirus play that popped up after traders started searching for companies that had products to treat respiratory problems. The stock was halted on Friday for a few mintues as traders rushed to buy up shares.

___

BCRX – a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases

NOTE: galidesivir is in a Phase 1 study for a range of viruses, including coronaviruses. The early stage of development may prohibit material contribution in the immediate outbreak, but BioCryst may be able to lend some useful data.

___

AEMD – a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression.

___

CODX – is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), and to sell diagnostic equipment from other manufacturers as self-contained lab systems.

NOTE: Similar to NNVC & NVAX, the company issued a secondary offering right after the one day spike. Investors gobbled up the dip quick on Friday.

____

CBLI – a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need.

__

LLIT – offers medical devices, including medical ventilators, general hospital products, medical compressors, and wireless medical products, as well as related supporting products.

NOTE: Similar to AHPI, the stock was halted serval times as traders went down the food chain for respirator products.

___

Feel free to add tickers to this list in the comment section.



Source link

قالب وردپرس

Share Market

Here are all the things that could go wrong in 2020, according to Nouriel Roubini

Published

on



From hot wars to weaponized financial assets, the U.S. faces severe economic, financial, political and geopolitical disturbances

In my 2010 book, “Crisis Economics,” I defined financial crises not as the “black swan” events that Nassim Nicholas Taleb described in his eponymous bestseller, but as “white swans.”

According to Taleb, black swans are events that emerge unpredictably, like a tornado, from a fat-tailed statistical distribution. But I argued that financial crises, at least, are more like hurricanes: They are the predictable result of built-up economic and financial vulnerabilities and policy mistakes.

There are times when we should expect the system to reach a tipping point — the “Minsky Moment” — when a boom and a bubble turn into a crash and a bust. Such events are not about the “unknown unknowns” but rather the “known unknowns.”

Financial markets remain blissfully in denial of the many predictable global crises that could come to a head this year, particularly in the months before the U.S. presidential election. In addition to the increasingly obvious risks associated with climate change, at least four countries want to destabilize the US from within.

Beyond the usual economic and policy risks that most financial analysts worry about, a number of potentially seismic white swans are visible on the horizon this year. Any of them could trigger severe economic, financial, political and geopolitical disturbances unlike anything since the 2008 crisis.

Four Powers

For starters, the United States is locked in an escalating strategic rivalry with at least four implicitly aligned revisionist powers: China, Russia, Iran and North Korea. These countries all have an interest in challenging the U.S.-led global order, and 2020 could be a critical year for them, owing to the U.S. presidential election and the potential change in U.S. global policies that could follow.

Under President Donald Trump, the U.S. is trying to contain or even trigger regime change in these four countries through economic sanctions and other means. Similarly, the four revisionists want to undercut American hard and soft power abroad by destabilizing the U.S. from within through asymmetric warfare.

If the U.S. election descends into partisan rancor, chaos, disputed vote tallies and accusations of “rigged” elections, so much the better for America’s rivals. A breakdown of the U.S. political system would weaken American power abroad.

Moreover, some countries have a particular interest in removing Trump.

The acute threat that he poses to the Iranian regime gives it every reason to escalate the conflict with the U.S. in the coming months — even if it means risking a full-scale war — on the chance that the ensuing spike in oil prices CL.1, -0.78%would crash the U.S. stock market DJIA, -0.78% SPX, -1.05% , trigger a recession and sink Trump’s re-election prospects.

Yes, the consensus view is that the targeted killing of Qassem Soleimani has deterred Iran, but that argument misunderstands the regime’s perverse incentives. War between U.S. and Iran is likely this year; the current calm is the one before the proverbial storm.

Cold War with China

. . .[more]

https://www.marketwatch.com/story/the-stock-market-is-ignoring-these-white-swan-events-that-could-upend-everything-roubini-warns-2020-02-18

submitted by /u/LightningPlus
[comments]



Source link

قالب وردپرس

Continue Reading

Share Market

Which Grocer Should You Invest in?

Published

on


Some of the most interesting (and profitable) investments stem from businesses that we interact with on a daily basis. Many of these businesses provide a service to us that we take for granted, and it’s that sense of necessity that makes some of those businesses great investment options.

An example of this is your local grocery store. Grocers are interesting investment options in that they perform a necessary service to us, much like a utility does, but unlike a utility bill, most of us enjoy buying groceries.

Today, let’s take a look at Loblaw (TSX:L) and Metro (TSX:MRU) to determine which grocer is the better fit for your portfolio.

The case for Loblaw

Loblaw is the larger of the two grocers, with a network of over 2,000 locations across Canada, including over 1,300 Shoppers Drug mart locations, Shoppers is the largest pharmacy in Canada and has benefited from the cross-selling of Loblaw-branded products in its stores in recent years.

Speaking of brands, Loblaw benefits from owning some of the most well-known brands, including President’s Choice and Life Brand. The company has also branched out into other areas in recent years, including offering financial services through its PC Financial arm and its clothing line Joe Fresh.

The most recent quarterly results are for the fourth quarter of 2019, announced earlier this year. In that quarter, Loblaw reported revenue of $11,590, reflecting an increase of 3.3%, or $372 million over the same period last year. Both the food and drug retail segments saw growth of 1.9% and 3.9%, respectively.

Adjusted EBITDA came in at $1,205 million, reflecting a $310 million, or 34.6% improvement over the same quarter in fiscal 2018.

In terms of a dividend, Loblaw offers investors a quarterly payout that works out to a 1.78% yield, which probably won’t resonate with investors looking for a dividend stock. The flip side of that argument is that Loblaw is a defensive investment in that people continue to buy their groceries irrespective of the economy, and Loblaw has hiked the dividend on a nearly annual basis for several years.

At time of writing, Loblaw trades at $69.50 with a P/E of 24.91.

The case for Metro

With a network of 950 food stores and 650 pharmacy locations, Metro is the smaller of the two companies. Unlike Loblaw’s presence across most of the country, Metro’s footprint is limited to Quebec and parts of Ontario.

In terms of results, the most recent available results are for the first quarter of 2020, which were released in December of 2019. During that quarter, Metro reported sales of $4,029.8 million, reflecting an increase of 1.3% over the prior year. Similar to Loblaw, much of that growth stemmed from the pharmacy segment, which saw same-store sales surge 3.6% in the quarter. Across Metro’s food segment the company saw same-store sales increase by 1.4%.

Adjusted net earnings for the quarter came in at $180.9 million, up 5.1% over the same period last year. Metro also announced a hike to its dividend in the amount of 12.5%, reflecting a payout range of 30-40% of the adjusted net earnings of the prior year. Metro’s dividend currently works out to a 1.45% yield.

Metro currently trades at just over $55 with a P/E of 20.75.

The better investment

Both Metro and Loblaw make compelling investment cases. Both have growing networks of stores, and both offer a complementary pharmacy network that benefits from cross-selling and easier access to new markets.

That being said, in my opinion, Loblaw is a better investment at the moment. Loblaw’s larger more diversified network of stores lends itself to a larger market of customers, with more growth potential.

5 TSX Stocks for Building Wealth After 50

BRAND NEW! For a limited time, The Motley Fool Canada is giving away an urgent new investment report outlining our 5 favourite stocks for investors over 50.

So if you’re looking to get your finances on track and you’re in or near retirement – we’ve got you covered!

You’re invited. Simply click the link below to discover all 5 shares we’re expressly recommending for INVESTORS 50 and OVER. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a brief time only.


Click Here For Your Free Report!

More reading

Fool contributor Demetris Afxentiou has no position in any of the stocks mentioned.



Source link

قالب وردپرس

Continue Reading

Share Market

Wall Street Week Ahead for the trading week beginning February 24th, 2020

Published

on



Good Saturday morning to all of you here on r/StockMarket. I hope everyone on this sub made out pretty nicely in the market this past week, and is ready for the new trading week ahead.

Here is everything you need to know to get you ready for the trading week beginning February 24th, 2020.

Coronavirus fears spoiled a solid earnings season and will further dominate markets ahead – (Source)


The coronavirus outbreak ruined for investors what was a solid earnings reporting season and is casting a pall on forecasts for this quarter and the rest of this year. And now with most of the earnings season in the books, look for the latest coronavirus headlines to fill the vacuum and weigh on stocks the rest of the month.


Fourth-quarter profit growth for S&P 500 companies came in at 3.1%, and if the energy sector is excluded, the growth rate was 6.0%, according to Refinitiv. Just about four weeks ago, analysts expected a slight decline.


However, the deluge of solid corporate results was largely overlooked by investors who are focusing on the spillover impact from the coronavirus on U.S. corporations. Stocks post losses this week as a jump in confirmed coronavirus cases and deaths deepened concerns about slowing global economic growth. Major U.S. companies including Apple, Coca-Cola and Procter & Gamble have sounded alarms on the disease, warning of a dent in profits down the road.


“The virus is totally underrated,” CNBC’s Jim Cramer said on Friday.“What I think is a little too premature is they all presume that it is going to be solved within a foreseeable time frame. At what point do we say that many, many companies are going to be hurt by the virus [and] we’re paying too much for stocks.”


‘More cautious than usual’

Wall Street analysts have been quick to slash their earnings expectations for the next quarter in light of the fast-spreading virus. Expectations for earnings growth in the first quarter have been cut in half to just 3.2% from more than 6% at the start of 2020, according to Refinitiv.


Companies themselves are also lowering guidance for earnings growth in the near future. There have been more U.S. companies issuing below-consensus guidance for the next quarter than those with upbeat forecasts, marking the weakest ratio in a February since 2014, according to Savita Subramanian, head of U.S. equity and quantitative strategy at Bank of America.


“While guidance is typically weak in the first quarter as corporates set a low bar, it has been more cautious than usual this earnings season, likely due to the coronavirus,” Subramanian said in a note.


Nearly half of the S&P 500 companies have cited coronavirus during their earnings call this season, according to FactSet. These companies’ average revenue exposure to China is 7.2%, compared to 4.8% exposure for the average S&P 500 company.


As of Friday, China’s National Health Commission reported more than 75,000 confirmed cases and over 2,000 deaths on the mainland. South Korea has also reported more than 200 cases. Meanwhile, World health officials said the outbreak in Iran is “very worrisome.”


“Lost in those headlines is corporate America’s impressive performance this earnings season,” John Lynch, LPL Financial’s chief investment strategist, said in a note. “Companies have done an admirable job growing profits considering stiff headwinds.”


This past week saw the following moves in the S&P:

(CLICK HERE FOR THE FULL S&P TREE MAP FOR THE PAST WEEK!)

Major Indices for this past week:

(CLICK HERE FOR THE MAJOR INDICES FOR THE PAST WEEK!)

Major Futures Markets as of Friday's close:

(CLICK HERE FOR THE MAJOR FUTURES INDICES AS OF FRIDAY!)

Economic Calendar for the Week Ahead:

(CLICK HERE FOR THE FULL ECONOMIC CALENDAR FOR THE WEEK AHEAD!)

Sector Performance WTD, MTD, YTD:

(CLICK HERE FOR FRIDAY'S PERFORMANCE!)
(CLICK HERE FOR THE WEEK-TO-DATE PERFORMANCE!)
(CLICK HERE FOR THE MONTH-TO-DATE PERFORMANCE!)
(CLICK HERE FOR THE 3-MONTH PERFORMANCE!)
(CLICK HERE FOR THE YEAR-TO-DATE PERFORMANCE!)
(CLICK HERE FOR THE 52-WEEK PERFORMANCE!)

Percentage Changes for the Major Indices, WTD, MTD, QTD, YTD as of Friday's close:

(CLICK HERE FOR THE CHART!)

S&P Sectors for the Past Week:

(CLICK HERE FOR THE CHART!)

Major Indices Pullback/Correction Levels as of Friday's close:

(CLICK HERE FOR THE CHART!

Major Indices Rally Levels as of Friday's close:

(CLICK HERE FOR THE CHART!)

Most Anticipated Earnings Releases for this week:

(CLICK HERE FOR THE CHART!)

Here are the upcoming IPO's for this week:

(CLICK HERE FOR THE CHART!)

Friday's Stock Analyst Upgrades & Downgrades:

(CLICK HERE FOR THE CHART LINK #1!)
(CLICK HERE FOR THE CHART LINK #2!)
(CLICK HERE FOR THE CHART LINK #3!)

Earnings Season Observations

The recent news that technology giant Apple would miss its fourth quarter 2020 revenue targets has understandably increased investor anxiety surrounding the potential economic impact of the coronavirus (now called COVID-19). Lost in those headlines is corporate America’s impressive performance this earnings season.

“Companies have done an admirable job growing profits considering stiff headwinds,” said LPL Financial Chief Investment Strategist John Lynch. “Despite slowing global economic growth, weakness in capital investment and manufacturing, a strong US dollar, and a huge drop in energy sector profits, S&P 500 companies are impressively grinding out 1-2 percentage points of overall earnings growth.” The fourth quarter earnings growth may cement the third quarter of 2019 as the trough, as shown in the LPL Chart of the Day below.

(CLICK HERE FOR THE CHART!)

Some highlights of this earnings season:

  • Solid revenue upside. A solid 65% of S&P 500 Index companies have beaten revenue estimates, the highest level since second quarter 2018 and well above the long-term average at 57%. S&P 500 companies have produced a larger-than-normal nearly one percentage point positive revenue surprise and are tracking to a 3.5% top-line increase.
(CLICK HERE FOR THE CHART!)
  • Respectable earnings upside despite headwinds. The earnings beat rate at 71% is slightly above the 10-year average (70%). S&P 500 earnings growth has surprised by a solid 4.4% so far despite economic, currency, and commodity headwinds.
(CLICK HERE FOR THE CHART!)
  • Consider the energy drag. Though 1-2% overall earnings growth isn’t much, the gain is approximately 4%, excluding the energy sector.
  • Sector standout. One of the most China-exposed sectors produced one of the biggest upside earnings surprises: Technology. Technology sector earnings growth is tracking to a 5% year-over-year increase, about 9 percentage points above prior estimates.
  • Reassuring outlooks. Estimates for S&P 500 earnings per share in 2020 have only fallen by about 0.9% since December 31, 2019. Though these numbers may come down a bit more in the coming days and the China situation remains fluid, this modest reduction reflects U.S. companies’ resilience overall amid significant supply chain disruptions.

Election Year March: Performance Haunted By Steep 1980 Declines

Boisterous March markets tend to drive prices up early in the month and batter stocks at month end. Julius Caesar failed to heed the famous warning to “beware the Ides of March” but investors have been served well when they have. Stock prices have a propensity to decline, sometimes rather precipitously, during the latter days of the month. In March 2001, DJIA plunged 1469 points (-11.8%) from March 9 to the 22.

Normally a decent performing market month, March is somewhat above average in election years with advances 64.7% of the time with a 1.0% average DJIA gain since 1952. S&P 500 has also advanced 64.7% of the time since 1952, but gains have been slightly better at 1.2%, on average. NASDAQ has not fared well in March in election years since 1972. Due to a 17.1% loss in 1980, March is NASDAQ’s second worst month of the election year. Similarly, March 1980’s steep losses adversely affect Russell 1000 and Russell 2000 indices.

(CLICK HERE FOR THE CHART!)

Performance Throughout The Presidencies

As markets were closed to observe Presidents Day yesterday and the 2020 Presidential election continues to ramp up, we thought it would be a good time to check up on stock performance during different administrations. In the table below, we show the performance of the Dow during the administrations of every US president since 1900 in addition to the annualized return. In the time since President Trump was sworn into office, the Dow has risen 46.9%. On an annualized basis, the 13.3% return places the current administration in 3rd place for the strongest performance. Only the Clinton administration in the 1990s and Coolidge administration in the 1920s have observed stronger annualized gains. The one caveat of course is that President Trump's term (or terms) has yet to end. Comparing Democratic and Republican administrations since 1900, Democratic presidencies have tended to average stronger returns than their Republican peers, so the stock market's returns under President Trump have deviated somewhat from the norm.

(CLICK HERE FOR THE CHART!)

While it is impossible to say what a candidate's election will mean for the market, at the moment betting markets favor the incumbent to win the presidency while Bernie Sanders and Michael Bloomberg go back and forth in taking the number 2 spot, hovering around 15%-16%. Come Super Tuesday (March 3rd) when we could finally see more clarity on the Democratic side, the back and forth between Bloomberg and Sanders might become more one-sided.

(CLICK HERE FOR THE CHART!)

Yet Another Corona Friday

The major indices decided it was five o'clock somewhere right off the bat today as they experience yet another "Corona Friday". More concerns around the coronavirus have sent stocks lower with the S&P 500 down around 1.1% as of this writing and the Nasdaq down nearly 2% today. Declines on a Friday have become par for the course in 2020. Fridays have been the weakest day of the week so far in 2020; the only one to average a decline. On average, the S&P 500 has fallen 0.52% on Fridays while the next worst day has been Monday which has averaged a gain of 0.19%. Fridays have also been the day that the S&P 500 has closed higher the least. Only 28.6% of Fridays this year have seen the S&P 500 finish in the green. That compares to a positive close more than three-quarters of the time on Mondays, Wednesdays, and Thursdays. While it has averaged a gain of 0.24%, Tuesdays have also experienced a positive close less than half of the time. Try Bespoke's premium research package for free for two weeks.

(CLICK HERE FOR THE CHART!)

New All-Time Highs for S&P 500 and NASDAQ – Well Above Average Gains in Election Year

As of today’s close, DJIA is up 2.84%, S&P 500 +4.81% and NASDAQ is up a whopping 9.41% year-to-date. All three indexes are well above their respective historical averages for this time of an election year. NASDAQ has in fact already exceeded its average full election year performance going back to 1972. Bullish sentiment and momentum appear to be firmly in place and historical election year patterns suggests strength could easily continue for DJIA and S&P 500 into May. NASDAQ’s surge higher could be vulnerable to a retreat sooner, in March.

(CLICK HERE FOR THE CHART!)

A Dow Without Boeing (BA)

For more than a year now, Boeing (BA) has been plagued by the 737 MAX crisis which has weighed on shares of the plane manufacturer with it now currently down nearly 20% from when the initial groundings took place on March 10th of last year. Despite this, while underperforming the broader market due to the 737 issues, the stock is actually still up just over 5% since the start of 2019.

Even though BA has lagged, it is still the highest-priced of the 30 stocks in the price-weighted Dow Jones Industrial Average. Currently trading around $338.50, the only stocks in the index holding a candle to BA are Apple (AAPL) and UnitedHealth (UNH), which also trade north of $300 per share. That means these stocks have the highest weighting in the index and therefore have a much larger impact than other stocks on the Dow's performance.

With BA's issues, a number of people have pondered the what-ifs for the Dow had the company not had the issues with the 737. Would we have already broken out the Dow 30K hats were it not for BA? In the chart below, we show the actual performance of the DJIA and have overlaid the performance of an 'alternate Dow' showing its performance if BA had not been in the index since the start of 2019. We used the start of 2019 instead of the actual date of the groundings as it is a little less arbitrary. By our calculations, while we would be a bit closer, even if BA wasn't in the index since the start of 2019, we wouldn't quite be at Dow 30K yet. As shown, our alternate Dow would be almost 1% or 266 points higher if Boeing was not included in the index since the start of 2019.

While BA has been a drag on the DJIA since last March, it also provided a big boost to the index in early 2018 before the 737 issues hit the stock. In fact, at the start of March 2017, BA was up over 36% YTD and the spread between the Dow's performance with and without BA was around 700 points in the other direction as it is now!

(CLICK HERE FOR THE CHART!)

Another example of this dynamic in which high priced stocks have a greater impact on the index was observed on Tuesday when Apple's (AAPL) stock fell after the company warned that Q1 revenues would be shy of prior guidance due to the coronavirus. The warnings sent shares down over 3% at its intraday lows, but the stock only finished down 1.83%. While there were equivalent or larger declines like Dow (DOW) or Walgreens Boots Alliance (WBA) in Tuesday's session, AAPL's declines by far weighed on the index more than any other stock. Of the Dow's 165.89 point decline, AAPL contributed 40.35 points. Fortunately, UNH helped to mitigate some of those losses as it had a positive impact on the index of +22.79 points.

(CLICK HERE FOR THE CHART!)

STOCK MARKET VIDEO: Stock Market Analysis Video for Week Ending February 21st, 2020

(CLICK HERE FOR THE YOUTUBE VIDEO!)

STOCK MARKET VIDEO: ShadowTrader Video Weekly 2.23.20

([CLICK HERE FOR THE YOUTUBE VIDEO!]())

(VIDEO NOT YET UP)


Here are the most notable companies (tickers) reporting earnings in this upcoming trading week ahead-


  • $BYND
  • $SQ
  • $HD
  • $SPCE
  • $CRM
  • $BIDU
  • $M
  • $CRON
  • $CHK
  • $BBY
  • $TTD
  • $AMRN
  • $SHAK
  • $KOS
  • $AWI
  • $SDC
  • $LOW
  • $ILPT
  • $CLVS
  • $TNDM
  • $IQ
  • $PANW
  • $CRI
  • $SPNS
  • $TJX
  • $CTB
  • $ETSY
  • $TREE
  • $KEYS
  • $INTU
  • $GWPH
  • $W
  • $TDOC
  • $WEN
  • $CROX
  • $DIN
  • $DNR
  • $LL
  • $DORM
  • $GH
  • $OXY
  • $MGI
  • $AMT
  • $JCP
  • $CBRL

(CLICK HERE FOR NEXT WEEK'S MOST NOTABLE EARNINGS RELEASES!)
(CLICK HERE FOR NEXT WEEK'S HIGHEST VOLATILITY EARNINGS RELEASES!)
(CLICK HERE FOR MOST ANTICIPATED EARNINGS RELEASES FOR THE MONTH OF FEBRUARY 2020!)

Below are some of the notable companies coming out with earnings releases this upcoming trading week ahead which includes the date/time of release & consensus estimates courtesy of Earnings Whispers:


Monday 2.24.20 Before Market Open:

(CLICK HERE FOR MONDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

Monday 2.24.20 After Market Close:

(CLICK HERE FOR MONDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #1!)
(CLICK HERE FOR MONDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #1!)

Tuesday 2.25.20 Before Market Open:

(CLICK HERE FOR TUESDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

Tuesday 2.25.20 After Market Close:

(CLICK HERE FOR TUESDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #1!)
(CLICK HERE FOR TUESDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #2!)

Wednesday 2.26.20 Before Market Open:

(CLICK HERE FOR WEDNESDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

Wednesday 2.26.20 After Market Close:

(CLICK HERE FOR WEDNESDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #1!)
(CLICK HERE FOR WEDNESDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #2!)

Thursday 2.27.20 Before Market Open:

(CLICK HERE FOR THURSDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES LINK #1!)
(CLICK HERE FOR THURSDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES LINK #2!)

Thursday 2.27.20 After Market Close:

(CLICK HERE FOR THURSDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #1!)
(CLICK HERE FOR THURSDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES LINK #2!)

Friday 2.28.20 Before Market Open:

(CLICK HERE FOR FRIDAY'S PRE-MARKET EARNINGS TIME & ESTIMATES!)

Friday 2.28.20 After Market Close:

([CLICK HERE FOR FRIDAY'S AFTER-MARKET EARNINGS TIME & ESTIMATES!]())

NONE.


Beyond Meat, Inc. $117.45

Beyond Meat, Inc. (BYND) is confirmed to report earnings at approximately 4:05 PM ET on Thursday, February 27, 2020. The consenus estimate is for breakeven results on revenue of $79.51 million and the Earnings Whisper ® number is $0.02 per share. Investor sentiment going into the company's earnings release has 73% expecting an earnings beat. Short interest has increased by 58.0% since the company's last earnings release while the stock has drifted higher by 41.6% from its open following the earnings release to be 4.1% below its 200 day moving average of $122.42. Overall earnings estimates have been revised higher since the company's last earnings release. The stock has averaged a 24.6% move on earnings in recent quarters.

(CLICK HERE FOR THE CHART!)


Square, Inc. $83.49

Square, Inc. (SQ) is confirmed to report earnings at approximately 4:05 PM ET on Wednesday, February 26, 2020. The consensus earnings estimate is $0.20 per share on revenue of $1.18 billion and the Earnings Whisper ® number is $0.24 per share. Investor sentiment going into the company's earnings release has 80% expecting an earnings beat The company's guidance was for earnings of $0.19 to $0.21 per share. Consensus estimates are for year-over-year earnings growth of 17.65% with revenue increasing by 26.54%. Short interest has decreased by 4.1% since the company's last earnings release while the stock has drifted higher by 34.9% from its open following the earnings release to be 23.8% above its 200 day moving average of $67.46. Overall earnings estimates have been revised lower since the company's last earnings release. On Thursday, February 20, 2020 there was some notable buying of 2,991 contracts of the $87.00 call expiring on Friday, February 28, 2020. Option traders are pricing in a 9.2% move on earnings and the stock has averaged a 7.9% move in recent quarters.

(CLICK HERE FOR THE CHART!)


Home Depot, Inc. $245.34

Home Depot, Inc. (HD) is confirmed to report earnings at approximately 6:00 AM ET on Tuesday, February 25, 2020. The consensus earnings estimate is $2.10 per share on revenue of $25.76 billion and the Earnings Whisper ® number is $2.15 per share. Investor sentiment going into the company's earnings release has 61% expecting an earnings beat. Consensus estimates are for earnings to decline year-over-year by 6.67% with revenue decreasing by 2.76%. Short interest has decreased by 17.3% since the company's last earnings release while the stock has drifted higher by 6.4% from its open following the earnings release to be 12.1% above its 200 day moving average of $218.79. Overall earnings estimates have been revised lower since the company's last earnings release. On Thursday, February 20, 2020 there was some notable buying of 1,015 contracts of the $245.00 call expiring on Friday, February 28, 2020. Option traders are pricing in a 4.0% move on earnings and the stock has averaged a 2.0% move in recent quarters.

(CLICK HERE FOR THE CHART!)


Virgin Galactic Holdings, Inc. $33.87

Virgin Galactic Holdings, Inc. (SPCE) is confirmed to report earnings at approximately 4:05 PM ET on Tuesday, February 25, 2020. Investor sentiment going into the company's earnings release has 56% expecting an earnings beat. The stock has drifted higher by 237.0% from its open following the earnings release. The stock has averaged a 3.8% move on earnings in recent quarters.

(CLICK HERE FOR THE CHART!)


Salesforce $189.50

Salesforce (CRM) is confirmed to report earnings at approximately 4:05 PM ET on Tuesday, February 25, 2020. The consensus earnings estimate is $0.55 per share on revenue of $4.75 billion and the Earnings Whisper ® number is $0.56 per share. Investor sentiment going into the company's earnings release has 81% expecting an earnings beat The company's guidance was for earnings of $0.54 to $0.55 per share. Consensus estimates are for earnings to decline year-over-year by 20.29% with revenue increasing by 31.83%. Short interest has decreased by 5.2% since the company's last earnings release while the stock has drifted higher by 18.2% from its open following the earnings release to be 19.5% above its 200 day moving average of $158.62. Overall earnings estimates have been revised lower since the company's last earnings release. On Thursday, February 20, 2020 there was some notable buying of 4,926 contracts of the $210.00 call expiring on Friday, June 19, 2020. Option traders are pricing in a 6.4% move on earnings and the stock has averaged a 3.9% move in recent quarters.

(CLICK HERE FOR THE CHART!)


Baidu, Inc. $129.80

Baidu, Inc. (BIDU) is confirmed to report earnings at approximately 4:30 PM ET on Thursday, February 27, 2020. The consensus earnings estimate is $2.72 per share on revenue of $3.96 billion and the Earnings Whisper ® number is $3.27 per share. Investor sentiment going into the company's earnings release has 72% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 39.49% with revenue increasing by 0.13%. Short interest has decreased by 30.4% since the company's last earnings release while the stock has drifted higher by 12.4% from its open following the earnings release to be 11.4% above its 200 day moving average of $116.53. Overall earnings estimates have been revised higher since the company's last earnings release. On Thursday, February 20, 2020 there was some notable buying of 2,013 contracts of the $125.00 put expiring on Friday, March 27, 2020. Option traders are pricing in a 7.0% move on earnings and the stock has averaged a 8.1% move in recent quarters.

(CLICK HERE FOR THE CHART!)


Macy's, Inc. $16.23

Macy's, Inc. (M) is confirmed to report earnings at approximately 6:55 AM ET on Tuesday, February 25, 2020. The consensus earnings estimate is $1.95 per share on revenue of $8.32 billion and the Earnings Whisper ® number is $1.98 per share. Investor sentiment going into the company's earnings release has 17% expecting an earnings beat. Consensus estimates are for earnings to decline year-over-year by 28.57% with revenue decreasing by 1.60%. Short interest has increased by 0.6% since the company's last earnings release while the stock has drifted higher by 13.5% from its open following the earnings release to be 9.6% below its 200 day moving average of $17.96. Overall earnings estimates have been revised lower since the company's last earnings release. On Tuesday, February 11, 2020 there was some notable buying of 8,128 contracts of the $16.00 put expiring on Friday, February 28, 2020. Option traders are pricing in a 8.4% move on earnings and the stock has averaged a 6.8% move in recent quarters.

(CLICK HERE FOR THE CHART!)


Cronos Group Inc. $7.15

Cronos Group Inc. (CRON) is confirmed to report earnings at approximately 7:00 AM ET on Thursday, February 27, 2020. The consensus estimate is for a loss of $0.04 per share on revenue of $12.40 million and the Earnings Whisper ® number is ($0.03) per share. Investor sentiment going into the company's earnings release has 65% expecting an earnings beat. Consensus estimates are for year-over-year earnings growth of 20.00% with revenue increasing by 192.38%. Short interest has increased by 28.4% since the company's last earnings release while the stock has drifted lower by 11.2% from its open following the earnings release to be 32.9% below its 200 day moving average of $10.66. Overall earnings estimates have been revised lower since the company's last earnings release. On Tuesday, February 11, 2020 there was some notable buying of 4,164 contracts of the $8.00 call expiring on Friday, February 28, 2020. Option traders are pricing in a 11.3% move on earnings and the stock has averaged a 3.6% move in recent quarters.

(CLICK HERE FOR THE CHART!)


Chesapeake Energy Corp. $0.45

Chesapeake Energy Corp. (CHK) is confirmed to report earnings at approximately 7:00 AM ET on Wednesday, February 26, 2020. The consensus estimate is for a loss of $0.06 per share on revenue of $1.21 billion and the Earnings Whisper ® number is ($0.07) per share. Investor sentiment going into the company's earnings release has 48% expecting an earnings beat. Consensus estimates are for earnings to decline year-over-year by 128.57% with revenue decreasing by 30.10%. Short interest has increased by 1.0% since the company's last earnings release while the stock has drifted lower by 66.1% from its open following the earnings release to be 67.6% below its 200 day moving average of $1.38. Overall earnings estimates have been revised lower since the company's last earnings release. On Friday, February 21, 2020 there was some notable buying of 10,872 contracts of the $1.50 put expiring on Friday, March 20, 2020. Option traders are pricing in a 14.5% move on earnings and the stock has averaged a 10.2% move in recent quarters.

(CLICK HERE FOR THE CHART!)


Best Buy Co., Inc. $90.26

Best Buy Co., Inc. (BBY) is confirmed to report earnings at approximately 7:00 AM ET on Thursday, February 27, 2020. The consensus earnings estimate is $2.76 per share on revenue of $15.09 billion and the Earnings Whisper ® number is $2.83 per share. Investor sentiment going into the company's earnings release has 71% expecting an earnings beat The company's guidance was for earnings of $2.65 to $2.75 per share. Consensus estimates are for year-over-year earnings growth of 1.47% with revenue increasing by 1.95%. Short interest has increased by 10.5% since the company's last earnings release while the stock has drifted higher by 16.9% from its open following the earnings release to be 21.3% above its 200 day moving average of $74.42. Overall earnings estimates have been revised higher since the company's last earnings release. Option traders are pricing in a 8.2% move on earnings and the stock has averaged a 7.3% move in recent quarters.

(CLICK HERE FOR THE CHART!)


DISCUSS!

What are you all watching for in this upcoming trading week?


I hope you all have a wonderful weekend and a great trading week ahead r/StockMarket.

submitted by /u/bigbear0083
[comments]



Source link

قالب وردپرس

Continue Reading

Trending